| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Po-Yu Chen, Chun-Hsin Chen, Chin-Kuo Chang, Chung-Feng Kao, Mong-Liang Lu, Shih-Ku Lin, Ming-Chyi Huang, Ling-Ling Hwang, Valeria Mondell. Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics. The international journal of neuropsychopharmacology. vol 22. issue 1. 2019-12-30. PMID:30204875. |
we investigated the association between orexin-a levels and metabolic syndrome in patients with schizophrenia treated with clozapine or less obesogenic antipsychotics compared with nonpsychiatric controls. |
2019-12-30 |
2023-08-13 |
Not clear |
| Alp Ucok, Elif Anıl Yağcıoğlu, Mustafa Yıldız, Semra Ulusoy Kaymak, Meram Can Saka, Rümeysa Taşdelen, Ayşen Esen Danacı, Şevin Hun Şeno. Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia. Psychiatry research. vol 275. 2019-12-30. PMID:30908979. |
reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia. |
2019-12-30 |
2023-08-13 |
Not clear |
| Alp Ucok, Elif Anıl Yağcıoğlu, Mustafa Yıldız, Semra Ulusoy Kaymak, Meram Can Saka, Rümeysa Taşdelen, Ayşen Esen Danacı, Şevin Hun Şeno. Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia. Psychiatry research. vol 275. 2019-12-30. PMID:30908979. |
the aim of this retrospective chart-review study was to investigate the causes of clozapine discontinuation in patients with treatment-resistant schizophrenia. |
2019-12-30 |
2023-08-13 |
Not clear |
| Alp Ucok, Elif Anıl Yağcıoğlu, Mustafa Yıldız, Semra Ulusoy Kaymak, Meram Can Saka, Rümeysa Taşdelen, Ayşen Esen Danacı, Şevin Hun Şeno. Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia. Psychiatry research. vol 275. 2019-12-30. PMID:30908979. |
our findings point out the importance of enhancing psychiatrists' ability to handle manageable side effects to minimize discontinuations and maximize the benefits of clozapine in patients with treatment-resistant schizophrenia. |
2019-12-30 |
2023-08-13 |
Not clear |
| Essam Daod, Amir Krivoy, Gal Shoval, Salman Zubedat, John Lally, Limor Vadas, Abraham Weizman, Alon Reshef, Boaz Bloc. Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: A nationwide survey. Psychiatry research. vol 275. 2019-12-30. PMID:30913436. |
psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: a nationwide survey. |
2019-12-30 |
2023-08-13 |
Not clear |
| Antonio F Pardiñas, Mariana Nalmpanti, Andrew J Pocklington, Sophie E Legge, Christopher Medway, Adrian King, John Jansen, Marinka Helthuis, Stanley Zammit, James MacCabe, Michael J Owen, Michael C O'Donovan, James T R Walter. Pharmacogenomic Variants and Drug Interactions Identified Through the Genetic Analysis of Clozapine Metabolism. The American journal of psychiatry. vol 176. issue 6. 2019-12-30. PMID:30922102. |
this study is the first to adopt the framework of genome-wide association studies (gwass) to discover genetic markers of clozapine plasma concentrations in a large sample of patients with treatment-resistant schizophrenia. |
2019-12-30 |
2023-08-13 |
Not clear |
| Andrea Galova, Patricia Berney, Jules Desmeules, Ioannis Sergentanis, Marie Besso. A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder. BMC psychiatry. vol 19. issue 1. 2019-12-16. PMID:30782143. |
there have been previous reported cases of cholinergic rebound in the literature; however, these reports described cholinergic rebound following cessation of high doses of clozapine in patients diagnosed with schizophrenia. |
2019-12-16 |
2023-08-13 |
Not clear |
| Tak Youn, Seong Hoon Jeong, Yong Sik Kim, In Won Chun. Long-term clinical efficacy of maintenance electroconvulsive therapy in patients with treatment-resistant schizophrenia on clozapine. Psychiatry research. vol 273. 2019-12-13. PMID:31207863. |
long-term clinical efficacy of maintenance electroconvulsive therapy in patients with treatment-resistant schizophrenia on clozapine. |
2019-12-13 |
2023-08-13 |
Not clear |
| Sophie E Legge, Antonio F Pardiñas, Marinka Helthuis, John A Jansen, Karel Jollie, Steven Knapper, James H MacCabe, Dan Rujescu, David A Collier, Michael C O'Donovan, Michael J Owen, James T R Walter. A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia. Molecular psychiatry. vol 24. issue 3. 2019-12-02. PMID:30647433. |
we sought to identify risk alleles in the first genome-wide association study of neutrophil levels during clozapine treatment, in 552 individuals with treatment-resistant schizophrenia and robustly inferred african genetic ancestry. |
2019-12-02 |
2023-08-13 |
Not clear |
| Morten Brix Schou, Ole Kristian Drange, Sverre Georg Sæthe. Differences between counties in the prescribing of clozapine. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. vol 139. issue 13. 2019-12-02. PMID:31556524. |
norwegian national guidelines recommend that clozapine be offered to patients with schizophrenia after two failed attempts with other antipsychotic drugs. |
2019-12-02 |
2023-08-13 |
Not clear |
| Ulrich Schall, Stanley V. Catts, Shail Chaturvedi, Barbara Liebert, Joanna Redenbach, Frini Karayanidis, Philip B. War. The effect of clozapine therapy on frontal lobe dysfunction in schizophrenia: neuropsychology and event-related potential measures. The international journal of neuropsychopharmacology. vol 1. issue 1. 2019-11-20. PMID:11281941. |
the effect of clozapine therapy on frontal lobe dysfunction in schizophrenia: neuropsychology and event-related potential measures. |
2019-11-20 |
2023-08-12 |
Not clear |
| Ulrich Schall, Stanley V. Catts, Shail Chaturvedi, Barbara Liebert, Joanna Redenbach, Frini Karayanidis, Philip B. War. The effect of clozapine therapy on frontal lobe dysfunction in schizophrenia: neuropsychology and event-related potential measures. The international journal of neuropsychopharmacology. vol 1. issue 1. 2019-11-20. PMID:11281941. |
there are several reports that performance-based measures as well as symptom ratings improve with clozapine in patients with schizophrenia who previously responded poorly to typical neuroleptic treatment. |
2019-11-20 |
2023-08-12 |
Not clear |
| Ulrich Schall, Stanley V. Catts, Frini Karayanidis, Philip B. War. Auditory event-related potential indices of fronto-temporal information processing in schizophrenia syndromes: valid outcome prediction of clozapine therapy in a three-year follow-up. The international journal of neuropsychopharmacology. vol 2. issue 2. 2019-11-20. PMID:11281974. |
auditory event-related potential indices of fronto-temporal information processing in schizophrenia syndromes: valid outcome prediction of clozapine therapy in a three-year follow-up. |
2019-11-20 |
2023-08-12 |
human |
| Allan Z. Safferman, Rafael Munn. Combining Clozapine with ECT. Convulsive therapy. vol 8. issue 2. 2019-11-20. PMID:11941161. |
we describe the safe and effective use of the combination of clozapine and ect in a patient with schizophrenia who had lost responsiveness to clozapine alone. |
2019-11-20 |
2023-08-12 |
Not clear |
| Cristiana Silvestrini, Tiziana Arcangeli, Massimo Biondi, Paola Pancher. A second trial of clozapine in a case of granulocytopenia. Human psychopharmacology. vol 15. issue 4. 2019-11-20. PMID:12404322. |
we report on the case of a 29-year-old woman with dsm-iv undifferentiated schizophrenia who developed agranulocytosis after 5 years of 300 mg/day clozapine treatment. |
2019-11-20 |
2023-08-12 |
Not clear |
| Yaffa Vered, Baruch Spivak, Allon Nechmad, Nina Schlapnikov, Eran Graff, Israel Feinberg, Daniel Gruper, Mordechai Weiss, Moshe Kotler, Abraham Weizman, Roberto Meste. Plasma serotonin response to carbohydrate-rich food in chronic schizophrenic patients: clozapine versus classic antipsychotic agents. Human psychopharmacology. vol 16. issue 5. 2019-11-20. PMID:12404560. |
in the present study, we used the carbohydrate-rich meal test as an indicator of 5-ht activity in 12 patients with chronic schizophrenia maintained for at least 6 months on clozapine. |
2019-11-20 |
2023-08-12 |
human |
| Yaffa Vered, Baruch Spivak, Allon Nechmad, Nina Schlapnikov, Eran Graff, Israel Feinberg, Daniel Gruper, Mordechai Weiss, Moshe Kotler, Abraham Weizman, Roberto Meste. Plasma serotonin response to carbohydrate-rich food in chronic schizophrenic patients: clozapine versus classic antipsychotic agents. Human psychopharmacology. vol 16. issue 5. 2019-11-20. PMID:12404560. |
our results indicate that in patients with chronic schizophrenia 5-ht responsivity to the natural challenge of carbohydrate-rich meals is lower in those treated with clozapine than in those given classic antipsychotic agents. |
2019-11-20 |
2023-08-12 |
human |
| Mohammad Sharaf. Comparison of Classical and Clozapine Treatment on Schizophrenia Using Positive and Negative Syndrome Scale of Schizophrenia (PANSS) and SPECT Imaging. International journal of medical sciences. vol 2. issue 2. 2019-11-20. PMID:15968344. |
comparison of classical and clozapine treatment on schizophrenia using positive and negative syndrome scale of schizophrenia (panss) and spect imaging. |
2019-11-20 |
2023-08-12 |
Not clear |
| Pichai Ittasakul, Anthony Archer, Jennifer Kezman, Wanlop Atsariyasing, Morris B Goldma. Rapid Re-challenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistance Schizophrenia Patient. Clinical schizophrenia & related psychoses. 2019-11-20. PMID:24047759. |
rapid re-challenge with clozapine following pronounced myocarditis in a treatment-resistance schizophrenia patient. |
2019-11-20 |
2023-08-12 |
Not clear |
| Scott R Clark, Lisa Wilton, Bernhard T Baune, Nicholas Procter, Harry Husti. A state-wide quality improvement system utilising nurse-led clinics for clozapine management. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. vol 22. issue 3. 2019-11-20. PMID:24811715. |
this paper describes the implementation of a state-wide clozapine management system to improve the quality of care for those with treatment-resistant schizophrenia. |
2019-11-20 |
2023-08-13 |
Not clear |